Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07254650 · ClinicalTrials.gov registry record · NA
Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT07254650 is a NA study that has not yet begun recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 300 participants.
The verdict
NCT07254650, a NA study, has not yet begun recruiting, sponsored by University of Texas Southwestern Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to assess how the location of local anesthetic medication affects pain control capabilities in adult patients undergoing thoracic(chest)-only minimally invasive surgery. The main questions it aims to answer are: * Is pain decreased when local analgesia is provided as a combination of serratus anterior plane block and intercostal nerve block when compared to either block administered individually? * How does location of local analgesia administration impact length-of-stay, cost-of-care, and quality-of-life? Researchers will compare three treatment options including long-acting local anesthetic (Exparel®) administered as (1) intercostal nerve block, (2) serratus anterior plane block, or (3) combination of intercostal nerve block and serratus anterior plane block to see if pain and opioid use are reduced dependent upon treatment group. All participants will receive a local anesthetic nerve block. Participants will be asked to describe their pain after surgery and to answer various questionnaires before and after surgery.
Interventions
- PROCEDURE Arm 1 "LipoB-I": Liposomal Bupivacaine via Multi-Level Intercostal Nerve Block
- PROCEDURE Arm 2 "LipoB-S": Liposomal Bupivacaine via Serratus Anterior Plane Block
- PROCEDURE Arm 3 "LipoB-C": Liposomal Bupivacaine Administered via Combination Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07254650
The ClinicalTrials.gov registry entry for NCT07254650 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Arm 1 "LipoB-I": Liposomal Bupivacaine via Multi-Level Intercostal Nerve Block is the first listed.
NCT07254650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07254650 about?
NCT07254650 is a clinical study titled "Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1". The goal of this clinical trial is to assess how the location of local anesthetic medication affects pain control capabilities in adult patients undergoing thoracic(chest)-only minimally invasive surgery. The main questions it aims to answer are: * Is pain decreased when local analgesia is provided...
What is the current status of trial NCT07254650?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-06. Estimated completion is 2028-01-01.
What interventions are being tested in trial NCT07254650?
The interventions under investigation include: Arm 1 "LipoB-I": Liposomal Bupivacaine via Multi-Level Intercostal Nerve Block (PROCEDURE), Arm 2 "LipoB-S": Liposomal Bupivacaine via Serratus Anterior Plane Block (PROCEDURE), Arm 3 "LipoB-C": Liposomal Bupivacaine Administered via Combination Block (PROCEDURE).
Who is sponsoring clinical trial NCT07254650?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.